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Abstract
1. For the settlement of carbon origin of urinary isovalthine, acetic acid-2-C14, valine-U-C14
or leucine-U-C14 was administered to rats together with isovaleric acid as an isovalthinuria in-
ducer, and urinary isovalthine excreted was tested by autoradiography. As the results of which, it
was found that these isotopic compounds were not the precursor of urinary isovalthine. Although
the isovalthinuria inducing effect of isovaleric acid was fairly diminished by these isotopic com-
pounds, urinary isovalthine was detected by paper electrophoresis. 2. Some metabolic products of
these isotopic compounds were also inquired in urine and some tissues. The results were as fol-
lows: a) Acetic acid incorporated into urea, aspartate, serine, glutamate, proline, glycine, alanine,
ornithine, ethanolamine, r-amino-buthyric acid (brain only), cholesterol and fatty acids. b) Valine
incorporated into urinary glutamate and glycine, and tissue cholesterol and fatty acids. Valine was
rapidly excreted in urine and found in a very small amount in liver digest. c) Leucine incorporated
into urinary aspartate, serine, glutamate and glycine, and tissue cholesterol and fatty acids. 3.
Several important problems of isovalthine studies to be elucidated were discussed.
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Isovalthine is a new sulfur-containing amino acid found in the urine
of some hypercholesterolemic patients and normal cat (1, 2). The method
of induction of isovalthinuria has been studied extensively in some normal
animals (3, 4, 5, 6). The sulfur atom of isovalthine has been found to
originate from cysteine or methionine (7). However, the carbon origin of
isovaleric acid residue in the isovalthine molecule has not been elucidated.
Isovaleric acid is a strong inducer of isovalthinuria in some normal animals
(3,6), but isovaleric acid _loCH or -4-Cl4 administered has never incorpora-
ted into urinary isovalthine (8, 9, 10).
For the elucidation of the carbon origin of isovalthine, further experi.
ments were carried out by using sodium acetate -2-Cl4, valine-V-Cl4, and
leucine-V-C-H to see if these radioactive compounds incorporate into
urinary isovalthine. As reported in a previous paper (6), acetic acid,
valine, or leucine was not an inducer of isovalthinuria by itself. So each
labeled compound was administered with non-labeled isovaleric acid as an
inducer. As the results of the present experiments, all isotopic compounds
tested have incorporated into tissue protein, cholesterol, fatty acids and
several urinary amino acids, but not into urinary isovalthine.
MATERIALS AND METHODS
Sodium acetate-2 C14, valine-U-CI4, and leucine-U-CI4 used were the com-
mercial products obtained from The Radioactive Center, Amersham, England.
The feeding of rats and the collection of urine were carried out by the same
procedure as described in a previous paper (0). Body weight of each rat and
volume of urine excreted were described in Table II. Each labeled compound
was diluted with respective non-labeled material and orally administered together
with sodium isovalerate (30 mg/rat/day) for 5 days. Each experimental group
was consisted of two rats and the amount of labeled compound administered was
as follows: sodium acetate-2-CI4, 30 mg/rat/day (total 1mc for two rats); valine-
U_CI4, 20 mg/rat/day (total 0.2 mc for two rats); leucine-U-CI4, 20 mg/rat/day
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(total O. I mc for two rats). After collecting the urine for 7 days, rats were killed
by decapitation, and the liver, kidney and brain were removed. The extraction
and the measurement of radioactivity of total tissue cholesterol and fatty acids
were carried out by the same procedure as described in a previous paper (10).
After extraction of lipids, each tissue digest was made weakly acidic with conc.
HCI and transferred on a column containing Diaion SK-I (H.form of sulfonated
cation exchanger, mesh 100). The column was washed with deionized water and
then eluted with 2N-NH3• The ammonia eluate was evaporated to dryness under
reduced pressure, and the residue was stored for amino acid analysis.
The collected urine of each group was adjusted to around pH 5 with acetic
acid and transferred to a column (A) containing Diaion SK-1 (H.form, mesh 100)
and the column was washed with deionized water. The effluent and washings
were combined and dried under reduced pressure. The residue was hydrolyzed
in 6N HCl for 20 hrs on a sand bath, and the hydrolysate was evaporated to
dryness under reduced pressure. The amino acids in the residue (Fraction I) was
collected by using another Diaion SK.l column (B) according to the same proce.
dure as described above.
Urinary NH2-free amino acids and peptides attached to the column (A) was
eluted with 2N NH3• The ammonia eluate was dried and dissolved in 0.2M
AcOH and filtered. The filtrate was transferred on a column containing Amber.
lite IR-4B (acetate form, mesh 100-200) and washed with 0.2M AcOH. The
effluent and washing were combined and dried. The residue (Fraction II) con·
tains mainly basic and neutral amino acids and peptides. The Amberlite column
was then washed with 2M AcOH and 2N HCl in that order, and each effluent
was dried. The 2M AcOH effluent (Fracton III) contains mainly acidic amino
acids and peptides, and the 2N HCl effluent (Fraction IV) strong acidic amino
acids and peptides.
The measurement of radioactivity and the quantitative determination of the
tissue and urinary amino acids were carried out simultaneously by an automatic
amino acid analyzer (Beckman Model 120 B) connected with Tri-Carb Flow
Monitor System (Packard Instrument Co. Inc., Model 3141) according to their
Manual.
RESULTS
1. Urinary Isovalthine
Isovalthine was usually found In the Fraction III, ar:d the same We: s
true in this experiment. But the Fraction III of all three experimental
groups have contained too small amount of isovalthine to be detected by
amino acid analyzer (sensitivity 0.1 p. mole). On paper electrophoresis
(sensitivity 0.01 11. mole), however, isovalthine was detected. So two
dimensional paper electrophoretogram, which was prepared by the methcd
of UBUKA (11), was exposed to autoradiography by the same procedure as
described in a previous paper (7), and it was found that isovalthine was
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not labeled in all the three groups. Thus the carbon of urinary isovalthine
was not derived from acetic acid, valine, or leucine. As will be discussed
later, acetic acid, valine, and leucine have diminished the isovalthinuria-
inducing-effect of isovaleric acid.
2. Amino Acids in Urine and Tissue Digest
(a) AcOH-2_C14 + Isovaleric Acid Group
The labeling pattern of amino acids in urine and tissue digest is
summarized in Table 1. Specific activities of alanine and glycine in the
tissue digest could not be calculated accurately. Some ninhydrin negative
compounds were detected to be labeled, but their nature was not charac-
terized.
Table 1 Specific Activity (cpm/Il mole) of Amino Acid, etc. in Urine and
Tissue Digest. (AcOH-2-C I4 +IVA Group)
Urine Liver Kidney Brain
Urea 5817
Serine + 152 262 73
Aspartic Acid 527
Glutamic Acid 267 604 448 275
Proline 775
Glycine 126 + + +
Alanine 262 + + +
Ornithine 185 185 101
Ethanolamine 98 98 56
?'-Aminobutyric Acid ,292
(b) Valine.U.C14 + Isovaleric Acid Group
Valine was the only labeled amino acid in tissue digest. In the Frac-
tion I of urine, however, glutamic acid and glycine were found to be
slightly labeled, and two unknown highly labeled ninhydrin negative
compounds were seen near the peaks of aspartate and cystine. Some
unknown labeled ninhydrin negative compounds were also found in urine
and tissue digest.
Specific activity of valine was as follows: urine, 17774 cpmlp. mole;
kidney, 3601 cpmlp. mole; brain, 83 cpml/1 mole. Surprisingly, very small
amount of valine was found in liver digest and the specific activity was
not calculated. These results will suggest the rapid excretion of. valine in
this instance. This might be due to the effect of isovaleric acid administered
simultaneously.
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(c) Leucine-U_C 14 + Isovaleric Acid Group
The specific activity of leucine in urine and tissue digest was as
follows: urine, 6410 cpmj11 mole; liver, 963 cpmj /1 mole; kidney, 781
cpm//1 mole; brain, 621 cpmj,a mole. .
Aspartic acid, serine, glutamic acid and glycine in the Fraction I of
urine were found to be slightly labeled, but leucine was the only labeled
amino acid in tissue digest. Some unknown labeled ninhydrin negative
compounds were also found in urine and tissue digest.
3. Tissue Cholesterol and Fatty Acids
As shown in Table 2, the isotopic carbons of valine and leucine are
used for the synthesis of cholesterol and fatty acids, though it seems less
than that of acetic acid.
Judging from the amount of radioactivity used, leucine (0. 1 mc) seems
Table 2 Incorporation of Radioactive Compounds into Tissue Lipids
(a) AcOH-2-CI4+ IVA Group (Urine volume: 170 ml/two rats/7 days;
Body weight of each rat: 185 & 180 gm)
Tissue Weight Cholesterol Fatty AcidsTissues (two rats) mg cpm/mg mg cpm/mg
Liver 7.40 4.9 1263 75.1 1347
Kidney 2.25 6.7 2161 112.7 1091
Brain 3.35 7.0 715 171.2 563
(b) Val-U-CI4+IVA Group (Urine volume: 210 ml/two rats/7 days;
Body weight of each rat: 210 & 220 gm)
Tissue Weight Cholesterol Fatty AcidsTissues (two rats) mg cpm/mg mg cpm/mg
Liver 10.85 14.7 248 286 64
Kidney 2.80 7.0 69 73.8 86
Brain 2.95 11.5 33 171.5 55
(c) Leu-U-CI4+IVA Group (Urine volume: 165 ml/two rats/7 days;
Body weight of each rat: 180 & 180 gm)
Tissue Weight Cholesterol Fatty AcidsTissues (two rats) mg cpm/mg mg cpm/mg
Liver 9.6 5.3 125 123.4 137
Kidney 2.7 6.4 91 104.2 147
Brain 3.2 8.6 153 109.7 89
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to be a better precursor for the synthesis of lipids than valine (0.2 me).
This may be due to the ketogenic character of leucine, though the rapid
excretion of valine should also be taken into account.
DISCUSSION
One of the most important problems remammg in the isovalthine
studies is the settlement of cabon origin of isovaleric acid residue in the
isovalthine molecule. The following compounds, most of which are known
to have intimate relation with cholesterol metabolism, have been found to
induce isovalthinuria in some normal animals (3, 4, 5, 6): isovaleric acid,
B-methylcrotonic acid, B-methylglutaconic acid, palmitic acid, methionine,
cysteine, bile acids, ..t-cholestenone, some hypocholesterolemic agents,
glucocorticoids, ACTH, and epinephrine. But these inducers are not
always sure. Even when most strong inducer such as isovaleric acid, bile
acid or glucocorticoid is administered, occasionally no isovalthinuria is
observed. Furthermore, some antagonistic phenomena are seen between
some strong inducers. For example, the simultaneous administrations of
the following combination never induce isovalthinuria (6): isovaleric acid
+ dehydrocholic acid, isovaleric acid + dexamethasone, dehydrocholic
acid +dexamethasone. It is also known that some non-inducers diminish or
inhibit the isovalthinuria-inducing effect of strong inducers (6). Thus the
exact condition necessary for isovalthinuria induction and the mechanism
of induction are still ambiguous at present. Therefore, it is quite hazardous
to select an isotopic compound tested for the settlement of carbon origin
of isovalthine.
The first trial by using variously labeled isovaleric acid has failed as
described in the preface. Isovaleric acid is the most sure and strong in-
d ucer, and isovalthine molecule is consisted of isovaleric acid and cysteine.
Nevertheless, labeled isovaleric acid administered never incorporates into
urinary isovalthine excreted. On the other hand, in vitro experiments,
guinea-pig liver homogenate can synthesize labeled S-(isopropyl carboxy-
methyl) glutathione (CSIV) from labeled isovaleric acid and glutathione,
and the cleavage of the labeled GSIV by kidney glutathionase gives labeled
isovalthine (12, 13, 14). Thus, in vitro experiments, labeled isovaleric acid
can be changed to labeled isovalthine. The discrepancy found between in
vivo and in vitro experiments will serve a warning on the studies of metabo-
lic pathway.
In the second trial described in this paper, labeled acetic acid, valine,
and leucine are used, because they are known to give isovaleric skeleton
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during their metabolism. Although these labeled compounds are non·in.
ducers by themselves and diminish the inducing effect of isovaleric acid,
a small amount of isovalthine is excreted and found to be not labeled in all
cases. The isotopic carbon of these compounds, however, are found to
incorporate into some other amino acids and lipids. Therefore, it may be
concluded that acetic acid, valine, or leucine is not a precursor of iso-
valthine.
SUMMARY
1. For the settlement of carbon origin of urinary isovalthine, acetic
acid-2-C 14, valine-U-C14 or leucine-U-C14 was administered to rats together
with isovaleric acid as an isovalthinuria inducer, and urinary isovalthine
excreted was tested by autoradiography. As the results of which, it was
found that these isotopic compounds were not the precursor of urinary
isovalthine.
Although the isovalthinuria inducing effect of isovaleric acid was fairly
diminished by these isotopic compounds, urinary isovalthine was detected
by paper electrophoresis.
2. Some metabolic products of these isotopic compounds were also
inquired in urine and some tissues. The results were as follows:
a) Acetic acid incorporated into urea, aspartate, serine, glutamate,
proline, glycine, alanine, ornithine, ethanolamine, r-amino-buthyric acid
(brain only), cholesterol and fatty acids.
b) Valine incorporated into urinary glutamate and glycine, and
tissue cholesterol and fatty acids. Valine was rapidly excreted in urine
and found in a very small amount in liver digest.
c) Leucine incorporated into urinary aspartate, serine, glutamate
and glycine, and tissue cholesterol and fatty acids.
3. Several important problems of isovalthine studies to be elucidated
were discussed.
REFERENCES
I. MIZUHARA, S. and OHMORI, S., Arch. Biochem. Biophys. 92, 53, 1961
2. OHMORI, S. and MIZUHARA, S.: Arch. Biochem. Biophys. 96, 179, 1962
3. FUKuToME, K.: Acta Med. Okayama 16, 241, 1962
4. UBUKA, T.: Acta Med. Okayama 17, 273, 1963
5. HORIUCHI, K.: Clin. Chim. Acta 12, 325, 1965
6. SHIMOMURA, T.: Acta Med. Okayama 19, 227, 1965
7. UBUKA, T., HORIUCHI, K., SHIMOMURA, T. and MIZUHARA, S.: Acta Med. Okayama 18,
65, 1964
6
Acta Medica Okayama, Vol. 23 [1969], Iss. 6, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss6/4
Experimental Isovalthinuria 503
8. FUKuToME, K.: Acta Med. Okayama 16, 247, 1962
9. OHMORI, S., UBUKA, T., SHIMOMURA, T., AZUMI, T. and HORIUCHI, K.: Acta Med.
Okayama 18, 351, 1964
10. KODAMA, K., AZUMI, T., SHIMOMURA, T. and FUJII, Y.: Acta Med. Okayama 20, 107,
1966
11. UBUKA, T.: j. Biochem. 52, 440, 1962
12. KUWAKI, T., OHMORI, S. and MIZUHARA, S.: Biochim. Biophys. Acta 78, 553, 1963
13. KUWAKI, T.: Acta Med. Okayama 18, 333, 1964
14. KUWAKI, T.: j. Biochem. 57, 126, 1965
7
Fjii: Experimental isovalthinuria. VII. Experiments with radioactive
Produced by The Berkeley Electronic Press, 1969
